Invasive pulmonary aspergillosis is associated with adverse clinical outcomes in critically ill patients receiving veno-venous extracorporeal membrane oxygenation-Reference-Cited by-同舟云学术

Invasive pulmonary aspergillosis is associated with adverse clinical outcomes in critically ill patients receiving veno-venous extracorporeal membrane oxygenation

Published:2018-04-06 Issue:7 Volume:37 Page:1251-1257
ISSN:0934-9723
Container-title:European Journal of Clinical Microbiology & Infectious Diseases
language:en
Short-container-title:Eur J Clin Microbiol Infect Dis

Author:

Rodriguez-Goncer I.,Thomas S.,Foden P.,Richardson M. D.,Ashworth A.,Barker J.,Geraghty C. G.,Muldoon E. G.,Felton T. W.

Funder

University of Manchester

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

http://link.springer.com/article/10.1007/s10096-018-3241-7/fulltext.html

Reference26 articles.

1. Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM et al (2009) Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet [Internet] Elsevier Ltd; 374(9698):1351–1363. Available from: https://doi.org/10.1016/S0140-6736(09)61069-2

2. Smith M, Vukomanovic A, Brodie D, Thiagarajan R, Rycus P, Buscher H (2017) Duration of veno-arterial extracorporeal life support (VA ECMO) and outcome: an analysis of the Extracorporeal Life Support Organization (ELSO) registry. Crit Care [Internet] 21(1):45 Available from: http://ccforum.biomedcentral.com/articles/10.1186/s13054-017-1633-1

3. Francischetti IMB, Szymanski J, Rodriguez D, Heo M, Wolgast LR (2017) Laboratory and clinical predictors of 30-day survival for patients on extracorporeal membrane oxygenation (ECMO): 8-year experience at Albert Einstein College of Medicine, Montefiore Medical Center. J Crit Care [Internet] Elsevier Inc. 40:136–144. Available from: https://doi.org/10.1016/j.jcrc.2017.03.027

4. Schmidt M, Bailey M, Sheldrake J, Hodgson C, Aubron C, Rycus PT et al (2014) Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure: the respiratory extracorporeal membrane oxygenation survival prediction (RESP) score. Am J Respir Crit Care Med 189(11):1374–1382

5. Hirshberg E, Miller 3rd RR, Morris AH (2013) Extracorporeal membrane oxygenation in adults with acute respiratory distress syndrome. Curr Opin Crit Care [Internet] Elsevier Inc; 19(1):38–43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23222676

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Veno-venous extracorporeal membrane oxygenation in severe acute respiratory failure;BJA Education;2024-02

2. Prediction of pulmonary aspergillosis in patients with ventilator-associated pneumonia;Annals of Intensive Care;2023-11-07

3. Long-Term Outcomes of Extracorporeal Life Support in Respiratory Failure;Journal of Clinical Medicine;2023-08-09

4. COVID-19 Is an Independent Risk Factor for Detrimental Invasive Fungal Disease in Patients on Veno-Venous Extracorporeal Membrane Oxygenation: A Retrospective Study;Journal of Fungi;2023-07-15

5. COVID-19 Associated Pulmonary Aspergillosis in Patients on Extracorporeal Membrane Oxygenation Treatment—A Retrospective Study;Journal of Fungi;2023-03-24